Penumbra (PEN) Return on Capital Employed (2015 - 2026)
Penumbra (PEN) posted quarterly Return on Capital Employed of 11.0% for Q2 2026, up 21.0% year-over-year from 9.09% in Q2 2025, and down 2.95% quarter-over-quarter from 11.34% in Q1 2026.
Penumbra (PEN) Return on Capital Employed (2015 - 2026) Analysis & Trends
Penumbra (PEN) has reported Return on Capital Employed for 12 consecutive years, with 11.0% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed rose 21.0% year-over-year to 11.0%; the TTM figure through Jun 2026 stood at 11.0% (up 21.0% YoY), while the FY2025 annual figure was 12.64%, up 1197.0% from the prior year.
- Return on Capital Employed retreated to 11.0% in Q2 2026 per PEN's latest filing, from 11.34% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 11.81% in Q4 2025 and bottomed at 3.27% in Q3 2022.
- Historically, Return on Capital Employed has averaged 3.81% across 5 years, with a median of 2.76% in 2025.
- Annual changes were most pronounced in 2024 — Return on Capital Employed sank 471 bps — and 2025, when it jumped 1230 bps.
- Penumbra's Return on Capital Employed stood at 0.51% in 2022, then jumped by 967 bps to 5.4% in 2023, then plunged by 87 bps to 0.69% in 2024, then jumped by 1616 bps to 11.81% in 2025, then decreased by 7 bps to 11.0% in 2026.
- Business Quant data shows PEN's Return on Capital Employed at 11.0% in Q2 2026, 11.34% in Q1 2026, and 11.81% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 11.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.00% |
| Mar 31, 2026 | 11.34% |
| Dec 31, 2025 | 11.81% |
| Sep 30, 2025 | 11.22% |
| Jun 30, 2025 | 10.79% |
| Mar 31, 2025 | 2.67% |
| Dec 31, 2024 | 0.69% |
| Sep 30, 2024 | 0.11% |
| Jun 30, 2024 | -1.51% |
| Mar 31, 2024 | 5.49% |
| Dec 31, 2023 | 5.40% |
| Sep 30, 2023 | 3.32% |
| Jun 30, 2023 | 2.85% |
| Mar 31, 2023 | 1.47% |
| Dec 31, 2022 | 0.51% |
| Sep 30, 2022 | -3.27% |
| Jun 30, 2022 | -3.03% |
| Mar 31, 2022 | -2.19% |
| Dec 31, 2021 | -0.76% |
| Mar 31, 2021 | -3.62% |